Psf3 as a possible biomarker of postoperative chemotherapy for patients with early pulmonary adenocarcinoma.
Kenji KimuraYugo TanakaShunsuke TauchiYoshitaka KitamuraWataru NishioYasuhiro SakaiYoshitake HayashiMasahiro YoshimuraYoshimasa ManiwaPublished in: Thoracic cancer (2019)
Appropriate patients of adjuvant chemotherapy for stage I pulmonary adenocarcinoma using Psf3 expression could be selected.